Neuro-Oncology Reviews

Volume 26 Number 26
20 November 2024

Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 26, 20 November

Al Shboul S, Singh A, Kobetic R, Goodlett DR, Brennan PM, Hupp T, Dapic I.
Mass Spectrometry Advances in Analysis of Glioblastoma.
Mass Spectrom Rev. 2024 Nov 11. doi: 10.1002/mas.21912. PMID: 39529217. Review˰ ˍ

Lawrence LSP, Maralani PJ, Das S, Sahgal A, Stanisz GJ, Lau AZ.
Magnetic resonance imaging techniques for monitoring glioma response to chemoradiotherapy.
J Neurooncol. 2024 Nov 11. doi: 10.1007/s11060-024-04856-3. PMID: 39527382. Review˰ ˍ

*Rahman R, Preusser M, Tsien C, Le Rhun E, Sulman EP, Wen PY, Minniti G, Weller M.
Point/Counterpoint: The role of reirradiation in recurrent glioblastoma.
Neuro Oncol. 2024 Nov 11:noae209. doi: 10.1093/neuonc/noae209. PMID: 39527460. Perspective. ˍ

Rusak A, Wiatrak B, Krawczyńska K, Górnicki T, Zagórski K, Zadka Ł, Fortuna W.
Starting points for the development of new targeted therapies for glioblastoma multiforme.
Transl Oncol. 2024 Nov 11;51:102187. doi: 10.1016/j.tranon.2024.102187. PMID: 39531784. Review. ˍ

Suero Molina E, Azemi G, Russo C, Liu S, Di Ieva A.
Artificial Intelligence in Brain Tumors.
Adv Exp Med Biol. 2024 Nov 11;1462:201-220. doi: 10.1007/978-3-031-64892-2_12. PMID: 39523267. Book chapter˰ ˍ

D'Arcy CE, Hawkins CE.
A pathologist's guide for the diagnostic workup of paediatric central nervous system tumours.
Pathology. 2024 Nov 12:S0031-3025(24)00290-3. doi: 10.1016/j.pathol.2024.10.002. PMID: 39658395. Review; Practical guide˰ ˍ

Khiabani NA, Doustvandi MA, Story D, Nobari SA, Hajizadeh M, Petersen R, Dunbar G, Rossignol J.
Glioblastoma therapy: State of the field and future prospects.
Life Sci. 2024 Nov 12;359:123227. doi: 10.1016/j.lfs.2024.123227. PMID: 39537100. Review˰ ˍ

Pfeffer LK, Fischbach F, Heesen C, Friese MA.
Current state and perspectives of CAR T cell therapy in central nervous system diseases.
Brain. 2024 Nov 12:awae362. doi: 10.1093/brain/awae362. PMID: 39530593. Review˰ ˍ

Rangwala HS, Shafique MA, Mustafa MS, Kumar R, Devi J, Rangwala BS, Ali SMS, Raja A, Iqbal J, Ali M, Haseeb A.
Evaluating efficacy and safety of laser interstitial thermal therapy in patients with newly diagnosed and recurrent glioblastoma: a systematic review and meta-analysis.
Neurosurg Rev. 2024 Nov 12;47(1):846. doi: 10.1007/s10143-024-03077-6. PMID: 39528836. Review; Meta-analysis˰ ˍ

Schonfeld E, Choi J, Tran A, Kim LH, Lim M.
The landscape of immune checkpoint inhibitor clinical trials in glioblastoma: A systematic review.
Neurooncol Adv. 2024 Nov 12;6(1):vdae174. doi: 10.1093/noajnl/vdae174. PMID: 39534539. Review. ˍ

Uslu U, June CH.
Beyond the blood: expanding CAR T cell therapy to solid tumors.
Nat Biotechnol. 2024 Nov 12. doi: 10.1038/s41587-024-02446-2. PMID: 39533105. Perspective˰ ˍ

Bazer DA, Wolff AC, Grossman SA.
Using a Pre-Radiation Window to Identify Potentially Active Cytotoxic Agents in Adults with Newly Diagnosed Glioblastoma.
Neuro Oncol. 2024 Nov 13:noae240. doi: 10.1093/neuonc/noae240. PMID: 39535058. Review˰ ˍ

Grutza M, Lenga P, Issa M, Seitz A, Sahm F, Milde T, Unterberg AW, Krieg SM, El Damaty A.
Pediatric skull base tumors: Clinical features and surgical outcomes; a single center retrospective study with a review of literature.
Brain Spine. 2024 Nov 13;4:104136. doi: 10.1016/j.bas.2024.104136. PMID: 39687083. Observational study; Review. ˍ

Ritchey AK, et al., PDQ Pediatric Treatment Editorial Board.
Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2024 Nov 13. NCBI Bookshelf ID: NBK65903. PMID: 26389341. Review. ˍ

Sabahi M, Fathi Jouzdani A, Sadeghian Z, Dabbagh Ohadi MA, Sultan H, Salehipour A, Maniakhina L, Rezaei N, Adada B, Mansouri A, Borghei-Razavi H.
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws.
J Neurooncol. 2024 Nov 13. doi: 10.1007/s11060-024-04876-z. PMID: 39538038. Review˰ ˍ

Darlix A, Preusser M, Hervey-Jumper SL, Shih HA, Mandonnet E, Taylor JW.
Who will benefit from vorasidenib? Review of data from the literature and open questions.
Neurooncol Pract. 2024 Nov 14;12(Suppl 1):i6-i18. doi: 10.1093/nop/npae104. PMID: 39776530. Review. ˍ

Meléndez-Vázquez NM, Gomez-Manzano C, Godoy-Vitorino F.
Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas.
Viruses. 2024 Nov 14;16(11):1775. doi: 10.3390/v16111775. PMID: 39599889. Review. ˍ

Raali R, Suresh P K.
Unraveling Glioblastoma: TME Implication and Gene Therapy Advances.
Curr Gene Ther. 2024 Nov 14. doi: 10.2174/0115665232351747241113050243. PMID: 39543872. Review˰ ˍ

Albert NL, Preusser M.
Theranostics and molecular imaging in Neuro-Oncology: the beginning of a new era.
Neuro Oncol. 2024 Nov 15:noae191. doi: 10.1093/neuonc/noae191. PMID: 39545472. Editorial. ˍ

Rodriguez B, Rivera D, Zhang JY, Brown C, Young T, Williams T, Kallos J, Huq S, Hadjpanayis C.
Innovations in intraoperative therapies in neurosurgical oncology: a narrative review.
J Neurooncol. 2024 Nov 15. doi: 10.1007/s11060-024-04882-1. PMID: 39546148. Review˰ ˍ

Valerio J, Borro M, Santiago Rea N, Valente L, Fernandez-Gomez MP, Zumaeta J, Mantilla P, Alvarez-Pinzon AM.
Radiosurgery for Hypothalamic Gliomas: A Case Report and Clinical Guidelines Form a Neurosurgical Center of Excellence.
J Pers Med. 2024 Nov 15;14(11):1108. doi: 10.3390/jpm14111108. PMID: 39590600. Case report; Guidelines. ˍ

AlSindi T, Alghamdi KT, Alghamdi AM, Samkari A, Kutub H.
Intraventricular Glioblastoma in a Neonate: A Case Report and Literature Review.
Cureus. 2024 Nov 16;16(11):e73797. doi: 10.7759/cureus.73797. PMID: 39691110. Case report; Review. ˍ

Nadeem SF, Fatima H, Javed Z, Shamim MS.
Radiation-Induced Leukoencephalopathy in Glioma Patients.
J Pak Med Assoc. 2024 Nov 17;74(12):2199-2201. doi: 10.47391/JPMA.24-101. PMID: 39658999. Review. ˍ

Spallotta F, Illi B.
The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?
Biomedicines. 2024 Nov 17;12(11):2631. doi: 10.3390/biomedicines12112631. PMID: 39595195. Review. ˍ

*Ventura N.
Understanding highand low-grade gliomas: VASARI criteria and MRI features.
Radiol Bras. 2024 Nov 18;57:e9. doi: 10.1590/0100-3984.2024.57.e9? PMID: 39640211. Editorial. ˍ

Alirezaei Z, Amouheidari A, BasirianJahromi R, Seyyedhosseini S, Hamidi A.
Survival Analysis of Glioblastoma: A Scientometric Perspective.
World Neurosurg. 2024 Nov 20:S1878-8750(24)01919-3? doi: 10.1016/j.wneu.2024.11.059? PMID: 39577630. Bibliometric analysis˰ ˍ

Beutler BD, Fan Z, Lerner A, Cua R, Zheng S, Rajagopalan P, Phung DC, Shiroishi MS, Sheikh-Bahaei N, Antwi-Amoabeng D, Assadsangabi R.
Pearls and Pitfalls of T1-Weighted Neuroimaging: A Primer for the Clinical Radiologist.
Acad Radiol. 2024 Nov 20:S1076-6332(24)00835-3. doi: 10.1016/j.acra.2024.10.048. PMID: 39572296. Education˰ ˍ

Wireko AA, Ben-Jaafar A, Kong JSH, Mannan KM, Sanker V, Rosenke SL, Boye ANA, Nkrumah-Boateng PA, Poornaselvan J, Shah MH, Abdul-Rahman T, Atallah O.
Sonic hedgehog signalling pathway in CNS tumours: its role and therapeutic implications.
Mol Brain. 2024 Nov 20;17(1):83. doi: 10.1186/s13041-024-01155-w. PMID: 39568072. Review. ˍ

Ziu M, Halasz LM, Kumthekar PU, McGranahan TM, Lo SS, Olson JJ.
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.
J Neurooncol. 2024 Nov 20. doi: 10.1007/s11060-024-04861-6. PMID: 39565459. Review; Guidelines˰ ˍ